Weekly Dose: flibanserin, the drug that gives women one extra sexually satisfying experience every two months
- Written by Jayne Lucke, Professor & Director of the Australian Research Centre in Sex, Health & Society, La Trobe University
Jinx!/Flickr, CC BY-SA
The United States Food and Drug Administration (FDA) approved the drug flibanserin (sold under the brand name Addyi) for the treatment of women with hypo-active sexual desire disorder (HSDD) in August 2015.
Australia hasn’t followed suit, though flibanserin is available...